Genes, Greens, and Homocysteine

Overview

Journal Heart

Date 1996 Aug 1

PMID 8795467

Citations 1

Authors

R A Meleady

D A Mulcahy

I M Graham

Affiliations

Soon will be listed here.

Citing Articles

Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.

Tokgozoglu S, Alikasifoglu M, Unsal , Atalar E, Aytemir K, Ozer N Heart. 1999; 81(5):518-22.

PMID: 10212171 PMC: 1729026. DOI: 10.1136/hrt.81.5.518.

References

McCully K . Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56(1):111-28. PMC: 2013581. View

Starkebaum G, Harlan J . Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986; 77(4):1370-6. PMC: 424498. DOI: 10.1172/JCI112442. View

Kang S, Wong P, SUSMANO A, Sora J, Norusis M, Ruggie N . Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991; 48(3):536-45. PMC: 1682970. View

Stampfer M, MALINOW M, Willett W, Newcomer L, Upson B, Ullmann D . A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992; 268(7):877-81. View

HARPEL P, Chang V, Borth W . Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci U S A. 1992; 89(21):10193-7. PMC: 50304. DOI: 10.1073/pnas.89.21.10193. View

Arnesen E, Refsum H, Bonaa K, Ueland P, Forde O, Nordrehaug J . Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995; 24(4):704-9. DOI: 10.1093/ije/24.4.704. View

Daly L, Robinson K, Tan K, Graham I . Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?. Q J Med. 1993; 86(10):685-9. DOI: 10.1093/qjmed/86.10.685. View

Pancharuniti N, Lewis C, SAUBERLICH H, Perkins L, Go R, Alvarez J . Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994; 59(4):940-8. DOI: 10.1093/ajcn/59.4.940. View

Wu L, Wu J, Hunt S, James B, Vincent G, Williams R . Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994; 40(4):552-61. View

10.

Mudd S, Levy H . Plasma homocyst(e)ine or homocysteine?. N Engl J Med. 1995; 333(5):325. DOI: 10.1056/NEJM199508033330520. View

11.

Boushey C, Beresford S, Omenn G, Motulsky A . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995; 274(13):1049-57. DOI: 10.1001/jama.1995.03530130055028. View

12.

Di Minno G, Davi G, Margaglione M, Cirillo F, Grandone E, Ciabattoni G . Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest. 1993; 92(3):1400-6. PMC: 288283. DOI: 10.1172/JCI116715. View